All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Top Biopharma Trends of 2021
    • Top Med-tech Trends of 2021
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, August 15, 2022
Home » Blogs » BioWorld MedTech Perspectives » MDD's Top 10 deals (so far) of '11

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

BioWorld MedTech

MDD's Top 10 deals (so far) of '11

July 14, 2011
By Amanda Pedersen
No Comments
Dollars seamless background.

Now that the first half of 2011 is already in our rearview mirror, Medical Device Daily has compiled a Top 10 list of the biggest deals so far this year. Admittedly, the list was inspired by the excitement of last week’s dealmaking activity – Medtronic to spend a total of $645 million to buy Salient Surgical Technologies and PEAK Surgical and TPG Capital buying Immucor for $1.97 billion.

So without further ado, here are the Top 10 deals MDD has reported on so far this year, not including any deals that closed this year but were first disclosed last year.

10. TPG Capital (Fort Worth, Texas) is buying Immucor (Norcross, Georgia) for $1.97 billion.

9. Health Care REIT (Toledo, Ohio) bought Genesis Healthcare (Kennett Square, Pennsylvania) for $2.4 billion.

8. Endo Pharmaceuticals (Chadds Ford, Pennsylvania) bought American Medical Systems (Minnetonka, Minnesota) in a $2.9 billion deal.

7. Ventas (Chicago) acquired 118 private-pay senior housing communities of Atria Senior Living Group (Louisville, Kentucky) for $3.1 billion.

6. Emergency Medical Services (Greenwood Village, Colorado) has agreed to be bought out by an affiliate of Clayton, Dubilier & Rice for $3.2 billion.

5. Thermo Fisher Scientific (Waltham, Massachusetts) seeks to acquire Phadia (Uppsala, Sweden) for roughly $3.5 billion.

4. A consortium of private equity investors plan to buy Kinetic Concepts (San Antonio) for $6.3 billion.

3. Danaher (Washington) plans to buy Beckman Coulter (Brea, California) for $6.8 billion.

2.  Ventas says it will acquire Nationwide Health Properties (New Port Beach, California) in a $7.4 billion stock-for-stock deal.

1. Johnson & Johnson (New Brunswick, New Jersey) says it will pay $21.3 billion for Synthes (Solothurn, Switzerland), making it one of the largest med-tech deals in history.

You must login or register in order to post a comment.

Report Abusive Comment

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld
    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Aug. 12, 2022.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Aug. 12, 2022.
  • Amvuttra

    Alnylam’s Amvuttra rare disease drug among positive recommendations from Europe’s CHMP

    BioWorld
    Alnylam Pharmaceuticals Inc.’s Amvuttra (vutrisiran), a treatment for the rare disease hereditary transthyretin-mediated amyloidosis, was among medicines...
  • Pig organ cells

    Whole body cellular function recovery in pigs after death

    Science
    A new system for restoring cell function and tissues in mammals after death could expand the availability of organs for transplantation. The research also opens...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Archives
    • Today's news
    • Search BioWorld Science
    • About
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing